NTPC Green Energy Ltd reported Q1 results for the quarter ended June 2026, with net profit rising 38.3% year on year and revenue increasing 62.7% to Rs 1,106.9 crore. EBITDA climbed 63.8% to Rs 988.7 crore, while EBITDA margin was 89.3%. The board approved setting up a wholly owned subsidiary (SPV) focused on renewable energy projects, and gave in-principle approval to invest up to Rs 28.78 lakh in its Andhra Pradesh joint venture AP NGEL Harit Amrit Ltd.

U.S. President Donald Trump said imported generic drugs will face a tiered tariff schedule starting Aug. 1, 2026, beginning with a two-year zero-rate period. He added the duty would rise to 100% in the third year and 200% from the fourth year onward to encourage manufacturers to shift generic drug production to the United States. The move directly affects Indian exporters such as Aurobindo Pharma and Sun Pharma, where U.S. shipments make up more than 30%–46% of FY26 revenue.

Indian precision manufacturing company Indo-MIM is launching a Rs 3,800 crore IPO priced at Rs 461–485 per share, with subscriptions opening on July 23 and listing scheduled for July 30. The deal includes a Rs 500 crore fresh issue and a Rs 3,312 crore offer for sale (OFS) by existing shareholders. The company said it plans to use part of the proceeds to repay debt and reported a 26% year-on-year increase in FY2026 profit and revenue. The IPO is described as a routine capital-raising exercise and does not involve policy shifts, systemic risks, or cross-market transmission mechanisms.

Axis Bank reported Q1FY27 net profit growth of 23% year on year, but its net interest margin fell 16 basis points quarter on quarter to 3.46%, below market expectations. The stock dropped 5.54% to Rs 1,255.25 in one session as investors reacted to the margin miss. Several foreign brokerages kept Buy ratings and set target prices in the Rs 1,490–1,700 range, while flagging NIM pressure as the key near-term constraint. Gross NPAs rose to 1.3% due to seasonal agri slippages, which analysts expect to ease.

Cipla said the U.S. Food and Drug Administration conducted a routine cGMP inspection at its wholly owned U.S. unit InvaGen’s manufacturing facility in Central Islip, Long Island, New York, from 13 July 2026 to 17 July 2026 (EDT). The company said it received one inspectional observation in Form 483 at the close of the inspection. Cipla added it will work with the USFDA and address the observation comprehensively within the stipulated time.

Tata Power has received a Letter of Award (LoA) from the Solar Energy Corporation of India Ltd. (SECI) to provide energy storage services from a 324 MW/2,592 MWh pumped storage plant for 40 years at a fixed annual charge. The company expects to commission the facility and start supplying the contracted storage capacity within 36 months from the effective date of the power purchase agreement (PPA). The project is priced at an annual fixed charge of Rs 1.0841826 crore per MW, implying about Rs 351.3 crore a year for the 324 MW contracted capacity, with an annual cycle loss of 24.61%.

India’s IT services firms Wipro and Tech Mahindra are set to report their fiscal 2025 first-quarter results for the June-ended period. The market expects Wipro’s revenue to rise 12–14% year on year while profit is seen largely flat, while Tech Mahindra’s profit is projected to jump 39–40% on 15–16% revenue growth. In pre-earnings trade, the two stocks were up 1.58% and 1.68%, respectively. Brokerages have also shared detailed forecasts spanning revenue, profit, margins and deal wins.

ICICI Lombard reported Q1 FY2025 results with net profit down 46% year on year, while its combined operating ratio (CoR) rose to 102.3%, missing market expectations. The quarter was hit by additional reserving in Motor TP following a Supreme Court verdict and a 32% drop in fire premiums as underwriting discipline tightened, pressuring both underwriting and investment income. Several brokerages cut earnings estimates, targets and ratings, after the stock fell 14.86% to Rs 1,544.40 and is down 17.85% year to date.

State-run power equipment maker Bharat Heavy Electricals Ltd (BHEL) is scheduled to post Q1 results for the quarter ended June 30 on July 16, 2026. Brokerages broadly expect revenue to rise 17–29% year on year, even as it is seen falling 42–47% sequentially. EBITDA and net profit are expected to drop sharply quarter on quarter, with some forecasts calling for both to turn negative. Market focus is on execution pace, margin pressure from new projects and the quality of order-to-revenue conversion, with the print seen as a “higher revenue, weaker profit” quarter that could drive near-term profit-taking in the stock.